Adjunctive brivaracetam versus placebo for partial seizures

Phase 3, randomised, double-blind trial in epilepsy and Focal Onset Epilepsy comparing Brivaracetam adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Incidence of treatment-emergent adverse events.